Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,282.15 +4.64 (+0.09%) Dow
38,575.10 -111.22 (-0.29%) Nasdaq
16,825.17 +90.15 (+0.54%) Bitcoin USD
69,245.83 +923.16 (+1.35%) CMC Crypto 200
1,499.26 +31.32 (+2.13%)
PROK Oct 2024 2.500 put
| Previous close | 0.4500 |
| Open | 0.5000 |
| Bid | 0.4000 |
| Ask | 0.9000 |
| Strike | 2.50 |
| Expiry date | 2024-10-18 |
| Day's range | 0.4500 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 50 |
GlobeNewswireProKidney to Participate in the Jefferies Global Healthcare Conference
WINSTON-SALEM, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the Jefferies Global Healthcare Conference taking place from June 4 – 6, 2024 in New York, NY. The ProKidney management team will host one-on-one meetings during the event. Interested investors should contact their
- GlobeNewswire
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
WINSTON-SALEM, N.C., May 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), will host a virtual KOL event on Tuesday, May 28, 2024 at 8:00 AM ET, featuring Steven G. Coca, DO, MS (Icahn School of Medicine at Mount Sinai) and Arnold L. Silva, MD, PhD (University of Arizona) who will discuss the unmet medical need and current treatment landscape for patients
Simply Wall St.We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
